Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Harvard Medical School, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Harvard Medical School, Medical Devices Deals, 2011 to YTD 2017 10
Harvard Medical School, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Harvard Medical School, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
ConSynance Therapeutics Enters into Research Agreement with Harvard Medical School 13
Imcare Biotech Enters into Partnership with Harvard Medical School 14
Astellas Pharma Enters into Research Agreement with Harvard Medical School 15
Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School 16
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 18
Ipsen Enters Into Research Agreement With Harvard Medical School To Discover Botulinum Toxins 19
Licensing Agreements 20
X-Biotix Therapeutics Enters into Licensing Agreement with Harvard Medical School 20
Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School 21
Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology 22
Mesoblast Enters into Licensing Agreement with Harvard Medical School 24
Columbia Labs Enters into Licensing Agreement for IVR Technology 25
GNS Healthcare Enters Into Licensing Agreement With Harvard Medical School 26
Harvard Medical School – Key Competitors 27
Harvard Medical School – Key Employees 28
Harvard Medical School – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Joint Venture 29
Recent Developments 30
Government and Public Interest 30
Oct 31, 2017: From Bench to Bedside: $4 Million Gift Supports Translational Medicine 30
Sep 15, 2017: New Study on the Placebo Effect and Antidepressants in Children and Adolescents 31
Sep 11, 2017: Scientists Construct First Predictive Model of Inflammatory Bowel Disease 32
Aug 31, 2017: Role of gut bacteria in averting Type 1 diabetes 33
Aug 21, 2017: Massachusetts Eye and Ear: Researchers identify key compounds to resolve abnormal vascular growth in age-related macular degeneration 35
Jul 19, 2017: DARPA: Building the Safe Genes Toolkit 37
Jun 27, 2017: Individualizing deep brain stimulation in patients with Parkinson’s disease 40
Apr 11, 2017: Researchers identify new target for abnormal blood vessel growth in the eyes 41
Feb 07, 2017: Cystinosis Research Foundation Grants Support Scientific Studies on Cell Function, New Treatments and the Quest for a Cure 42
Sep 19, 2016: True Health Diagnostics’ Proprietary Testing Underpins Harvard Study on Diet, Cardiac Function 44
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 45
Jun 20, 2016: Breast Cancer Cells Use Newfound Pathway to Survive Low Oxygen Levels in Tumors 47
Feb 02, 2016: New drug target for Rett syndrome 49
Product News 50
Nov 16, 2016: Next-generation biomaterial being developed to treat bleeding 50
May 19, 2016: Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment 51
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
Harvard Medical School, Pharmaceuticals & Healthcare, Key Facts 2
Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Harvard Medical School, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Harvard Medical School, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Harvard Medical School, Deals By Therapy Area, 2011 to YTD 2017 9
Harvard Medical School, Medical Devices Deals, 2011 to YTD 2017 10
Harvard Medical School, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
ConSynance Therapeutics Enters into Research Agreement with Harvard Medical School 13
Imcare Biotech Enters into Partnership with Harvard Medical School 14
Astellas Pharma Enters into Research Agreement with Harvard Medical School 15
Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School 16
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 18
Ipsen Enters Into Research Agreement With Harvard Medical School To Discover Botulinum Toxins 19
X-Biotix Therapeutics Enters into Licensing Agreement with Harvard Medical School 20
Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School 21
Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology 22
Mesoblast Enters into Licensing Agreement with Harvard Medical School 24
Columbia Labs Enters into Licensing Agreement for IVR Technology 25
GNS Healthcare Enters Into Licensing Agreement With Harvard Medical School 26
Harvard Medical School, Key Competitors 27
Harvard Medical School, Key Employees 28
Harvard Medical School, Subsidiaries 29
Harvard Medical School, Joint Venture 29